The EchoLUTION portfolio: achieve better results with less effort for your DNA and RNA extractions
In addition to insisting on superior quality, convenience and speed, BioEcho focuses on ecological responsibility by reducing plastic waste by >50%, using only biodegradable packaging material and avoiding hazardous reagents wherever possible. All this comes together in our EchoLUTION product line: one-step nucleic acid purification technology based on negative chromatography.
BioEcho's products are suited for multiple areas of biotechnology, including genomics, transcriptomics, next generation sequencing, biobanking, forensics, pathology, veterinary, food research, as well as industrial, medical and academic research.
BioEcho has received the confirmation from the German ministry of economics (bmwi) that investments by private investors into BioEcho can now be partially refunded tax-free - Bafa Invest: Zuschuss für Wagniskapital
... read more!
BioEcho has recently launched a crowd investing campaign with our platform partner medifundo:
BioEcho is about to close its first financing round. As one of the components, we have recently launched a crowd investing campaign with our platform partner medifundo... read more!